[1]王超,孙鑫*.SARS-CoV-2及COVID-19的研究进展[J].镇江高专学报,2020,33(03):113-116.
 WANG Chao,SUN Xin*.Research progress of SARSCoV2 and COVID19[J].Journal of Zhenjiang College,2020,33(03):113-116.
点击复制

SARS-CoV-2及COVID-19的研究进展()
分享到:

《镇江高专学报》[ISSN:/CN:]

卷:
33
期数:
2020年03期
页码:
113-116
栏目:
中学教学研究
出版日期:
2020-07-31

文章信息/Info

Title:
Research progress of SARSCoV2 and COVID19
文章编号:
1008-8148 (2020)03-0113-04
作者:
王超1孙鑫2*
(1. 镇江高等专科学校 卫生护理学院,江苏 镇江212028; 2. 镇江市中心血站 检验科,江苏 镇江212004)
Author(s):
WANG Chao1 SUN Xin2*
(1. School of Health and Nursing, Zhenjiang College, Zhenjiang 212028 China; 2. Clinical Laboratory, Zhenjiang Central Blood Bank, Zhenjiang 212004, China)
关键词:
SARS CoV2COVID19生物学特征临床特点
Keywords:
SARSCoV2 COVID19 biological characteristics clinical characteristics
分类号:
R563
文献标志码:
A
摘要:
新型冠状病毒肺炎(COVID19)是由一种新型冠状病毒(SARSCoV2)感染导致的传染性疾病。SARSCoV2以呼吸道飞沫和密切接触为主要传播途径,传染性极强。截至目前,尚无针对该病毒的疫苗及特效药物。通过查阅国内外文献,对SARSCoV2及COVID19的病原生物学特点、流行病学、致病机制、临床特点、治疗方法等方面进行综述。
Abstract:
Coronavirus disease 2019 (COVID19) is a contagious disease caused by a new coronavirus (SARSCoV2) infection. SARSCoV2 is mainly transmitted by respiratory droplets and close contact, and is highly infectious. Up to now, there is no vaccine or specific drug for this virus. In this thesis, the biological characteristics, epidemiology, pathogenesis, clinical characteristics and treatment methods of SARSCoV2 and the COVID19 were reviewed by consulting the domestic and foreign literatures

参考文献/References:

[1].\[1\] TANG Q, SONG Y L, SHI M J, et al. Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition\[J\].Scientific Reports,2015,5(1):1-8.
[2].\[2\] WU A, PENG Y, HUANG B, et al. Genome Composition and Divergence of the Novel Coronavirus(2019nCoV)Originating in China\[J\].Cell Host Microbe,2020,27(3):325-328.
[3].\[3\] LI F. Evidence for a common evolutionary origin of coronavirus spike protein receptorbinding subunits\[J\].Journal of Virology,2012,86(5):2856-2858.
[4].\[4\] HULSWIT R J, DE HAAN C A, BOSCH B J. Coronavirus Spike Protein and Tropism Changes\[J\].Advances in Virus Research,2016,96:29-57.
[5].\[5\] SONG Z Q, XU Y F, BAO L L, et al. From SARS to MERS, Thrusting Coronaviruses into the Spotlight\[J\].Viruses ,2019,11(1):59.
[6].\[6\] WOO P C Y, LAU S K P, LAM C S F, et al. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus\[J\].Journal of Virology,2012, 86(7):3995-4008.
[7].\[7\] CHAN J F, TO K K, TSE H, et al. Interspecies transmission and emergence of novel viruses: lessons from bats and birds\[J\].Trends in Microbiology,2013,21(10):544-555.
[8].\[8\] SU S, WONG G, SHI W, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses\[J\].Trends in Microbiology,2016,24(6):490-502.
[9].\[9\] ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin\[J\].Nature ,2020,579(7798):270-273.
[10].\[10\] CHAN J F, KOK K H, ZHU Z, et al. Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\[J\].Emerging Microbes Infections,2020,9(1):221-236.
[11].\[11\] 李天志,徐国纲.新型冠状病毒肺炎诊治研究进展\[J\].解放军医学杂志,2020,45(3):260-264.
[12].\[12\] 苏石,李小承,蒿花,等.新型冠状病毒的研究进展\[J\].西安交通大学学报(医学版),2020,41(4):479-482,496.
[13].\[13\] HAMMING I, TIMENS W, BULTHUIS M L, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis\[J\].Journal of Pathology,2004,203(2):631-637.
[14].\[14\] 韩姣,董咸峰,胡芬,等.核酸阳性新型冠状病毒感染120例临床特征分析\[J\].广东医学,2020,41(8):772-775.
[15].\[15\] WANG W, TANG J, WEI F. Updated understanding of the outbreak of 2019 novel coronavirus(2019nCoV)in Wuhan, China\[J\].Journal of Medical Virology,2020,92(4):441-447.
[16].\[16\] LI F. Structure, Function, and Evolution of Coronavirus Spike Proteins\[J\].Annual Review of Virology,2016,3(1):237-261.
[17].\[17\] HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, et al. SARSCoV2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor\[J\].Cell,2020,181(2):271-280.
[18].\[18\] LI W, ZHANG C, SUI J, et al. Receptor and viral determinants of SARScoronavirus adaptation to human ACE2\[J\].EMBO Journal,2005,24(8):1634-1643.
[19].\[19\] Burrell L M, Harrap S B, Velkoska E, et al. The ACE2 gene: its potential as a functional candidate for cardiovascular disease\[J\].Clinical Science,2013,124(2):65-76.
[20].\[20\] KUBA K, IMAI Y, RAO S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus induced lung injury\[J\].Nature Medicine,2005,11(8):875-879.
[21].\[21\] 熊娟,江万里,周倩,等.新型冠状病毒肺炎89例临床特征、治疗及预后分析\[J\].武汉大学学报(医学版),2020,41(4):542-546.
[22].\[22\] 房晓伟,梅清,杨田军,等.2019新型冠状病毒感染的肺炎79例临床特征及治疗分析\[J\].中国药理学通报,2020,36(4):453-459.
[23].\[23\] WANG D, HU B, HU C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China\[J\].The Journal of the American Medical Association,2020,323(11):1061-1069.
[24].\[24\] XU Z, SHI L, WANG Y, et al. Pathological findings of COVID19 associated with acute respiratory distress syndrome\[J\].Lancet Respiratory Medicine,2020,8(4):420-422.
[25].\[25\] CHEN N S, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study\[J\].The Lancet,2020,395(10223):507-513.
[26].\[26\] ZOU L, RUAN F, HUANG M, et al. SARSCoV2 Viral Load in Upper Respiratory Specimens of Infected Patients\[J\].New England Journal of Medicine,2020,382(12):1177-1179.
[27].\[27\] 李泉,刘钉宾,乔正荣,等.SARSCoV2 IgM/IgG抗体检测在新型冠状病毒肺炎诊断中的价值\[EB/OL\].(2020-03-04)\[2020-03-20\].国际检验医学杂志. http://kns.cnki.net/kcms/detail/50.1176.r.20200304.1041.006.html.
[28].\[28\] 罗效梅,王静,张娅,等.全血SARSCoV2特异性抗体检测对2019冠状病毒病的临床应用价值分析\[J\].西南大学学报(自然科学版),2020,42(3):30-34.
[29].\[29\] MAIRJENKINS J, SAAVEDRACAMPOS M, BAILLIE J K, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta analysis\[J\].Journal of Infectious Diseases,2015,211(1):80-90.

备注/Memo

备注/Memo:
收稿日期: 2020-03-24?
作者简介: 王超(1987—),男,山东新泰人,助教,硕士,主要从事炎症免疫研究;孙鑫(1989—),女,江苏镇江人,主管技师,硕士,主要从事临床检验研究。*为通讯作者。
更新日期/Last Update: 2020-09-20